The dopamine transporter gene SLC6A3: multidisease risks

Academic Article


  • The human dopamine transporter gene SLC6A3 has been consistently implicated in several neuropsychiatric diseases but the disease mechanism remains elusive. In this risk synthesis, we have concluded that SLC6A3 represents an increasingly recognized risk with a growing number of familial mutants associated with neuropsychiatric and neurological disorders. At least five loci were related to common and severe diseases including alcohol use disorder (high activity variant), attention-deficit/hyperactivity disorder (low activity variant), autism (familial proteins with mutated networking) and movement disorders (both regulatory variants and familial mutations). Association signals depended on genetic markers used as well as ethnicity examined. Strong haplotype selection and gene-wide epistases support multimarker assessment of functional variations and phenotype associations. Inclusion of its promoter region’s functional markers such as DNPi (rs67175440) and 5’VNTR (rs70957367) may help delineate condensate-based risk action, testing a locus-pathway-phenotype hypothesis for one gene-multidisease etiology.
  • Authors

    Published In

    Digital Object Identifier (doi)

    Author List

  • Reith MEA; Kortagere S; Wiers CE; Sun H; Kurian MA; Galli A; Volkow ND; Lin Z
  • Start Page

  • 1031
  • End Page

  • 1046
  • Volume

  • 27
  • Issue

  • 2